Clinical Trials List
2005-05-01 - 2006-12-31
Phase III
Terminated3
ICD-10I61.0
Nontraumatic intracerebral hemorrhage in hemisphere, subcortical
ICD-10I61.1
Nontraumatic intracerebral hemorrhage in hemisphere, cortical
ICD-10I61.2
Nontraumatic intracerebral hemorrhage in hemisphere, unspecified
ICD-10I61.3
Nontraumatic intracerebral hemorrhage in brain stem
ICD-10I61.4
Nontraumatic intracerebral hemorrhage in cerebellum
ICD-10I61.5
Nontraumatic intracerebral hemorrhage, intraventricular
ICD-10I61.6
Nontraumatic intracerebral hemorrhage, multiple localized
ICD-10I61.8
Other nontraumatic intracerebral hemorrhage
ICD-10I61.9
Nontraumatic intracerebral hemorrhage, unspecified
ICD-9431
Intracerebral hemorrhage
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
816 participants
